A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.

NCT07669454 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Fatigue Related to Cancer Treatment
Colon Cancer

Interventions

DRUG: Nuvastatic 300
DRUG: Placebo

Sponsor

Natureceuticals Sdn Bhd